ACRV vs BRO · $65.1M cap vs P/E 30, rev $3.58B
Acrivon Therapeutics, Inc. Common Stock (ACRV) versus Brown & Brown Inc (BRO) — a side-by-side from cached financials, not a winner call.
Acrivon Therapeutics, Inc. Common Stock (ACRV) is a biotechnology company listed on NASDAQ.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
ACRV does not have a complete income-statement cache yet.
Latest reported BRO revenue for 2026-06-30 was $3.58B. Net income was $714.0M. Revenue was up 88.2% from 2026-03-31 to 2026-06-30. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
ACRV currently screens at market cap $65.1M. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Not investment advice. Open the ACRV and BRO stock pages for the full models.
Not investment advice.